A multicentre retrospective analysis on pentostatin as salvage therapy of severe steroid refractory acute graft-versus-host disease of the gastro-intestinal tract

被引：0
|
作者：
Klein, S. A.
Schmitt, T.
Bug, G.
Schetelig, J.
Schwerdtfeger, R.
Schaefer-Eckart, K.
Schmid, C.
Kobbe, G.
Heidenreich, D.
Bornhaeuser, M.
Martin, H.
Dreger, P.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [21] Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 146 - 148
  • [22] COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Van Groningen, L.
    Liefferink, A.
    de Haan, A.
    Schaap, N.
    Donnelly, P.
    Blijlevens, N.
    van der Velden, W.
    HAEMATOLOGICA, 2015, 100 : 279 - 279
  • [23] Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
    van Groningen, Lenneke F. J.
    Liefferink, Aleida M.
    de Haan, Anton F. J.
    Schaap, Nicolaas P. M.
    Donnelly, J. Peter
    Blijlevens, Nicole M. A.
    van der Velden, Walter J. F. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 179 - 182
  • [24] Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
    Ganetsky, Alex
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Gill, Saar I.
    Luger, Selina M.
    Mangan, James K.
    Martin, Mary Ellen
    Babushok, Daria V.
    Drobyski, William R.
    Smith, Jacqueline
    Timlin, Colleen
    Freyer, Craig W.
    Stadtmauer, Edward A.
    Porter, David L.
    BONE MARROW TRANSPLANTATION, 2019, 54 (02) : 212 - 217
  • [25] Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
    Alex Ganetsky
    Noelle V. Frey
    Elizabeth O. Hexner
    Alison W. Loren
    Saar I. Gill
    Selina M. Luger
    James K. Mangan
    Mary Ellen Martin
    Daria V. Babushok
    William R. Drobyski
    Jacqueline Smith
    Colleen Timlin
    Craig W. Freyer
    Edward A. Stadtmauer
    David L. Porter
    Bone Marrow Transplantation, 2019, 54 : 212 - 217
  • [26] Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract
    Ganetsky, Alex
    Frey, Noelle V.
    Loren, Alison W.
    Hexner, Elizabeth O.
    Mangan, James K.
    Gill, Saar I.
    Luger, Selina
    Cohen, Adam D.
    Babushok, Daria V.
    Stadtmauer, Edward A.
    Smith, Jacqueline
    Drobyski, William R.
    Kraus, Sarah K.
    Timlin, Colleen
    Porter, David L.
    BLOOD, 2016, 128 (22)
  • [27] Tocilizumab for steroid refractory acute graft-versus-host disease
    Roddy, Julianna V. F.
    Haverkos, Bradley M.
    McBride, Ali
    Leininger, Kathryn M.
    Jaglowski, Samantha
    Penza, Sam
    Klisovic, Rebecca
    Blum, William
    Vasu, Sumithira
    Hofmeister, Craig C.
    Benson, Don M.
    Andritsos, Leslie A.
    Devine, Steven M.
    Efebera, Yvonne A.
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 81 - 85
  • [28] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [29] Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease
    Yamin, T.
    Yi, L.
    Kaili, D.
    He, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S393 - S394
  • [30] Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
    Fante, M. A.
    Wertheimer, T.
    Holler, B.
    Kattner, A. -S.
    Martinovic, D.
    Hoepting, M.
    Weber, D.
    Edinger, M.
    Holler, E.
    Herr, W.
    Wolff, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 284 - 285
12345